• El.En.’s pretax profit climbed 40% year over year to EUR 68.83 million in the first nine months of 2026.
• Revenue rose 8% to EUR 362.99 million, while medical revenue increased 9% to EUR 334.99 million.
• Net cash increased to EUR 192.6 million at September 30 from EUR 172.21 million at December 31, 2025.
• The group completed the sale of an 80% stake in Cutlite to TRUMPF on November 5, receiving EUR 13 million at closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. El.En. S.p.A. published the original content used to generate this news brief on November 13, 2026, and is solely responsible for the information contained therein.